• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

March 22, 2006

View Archived Issues

Research Foundations of Orion and Farmos plan to merge

Read More

Laureate Pharma and Bradmer sign development and manufacturing agreement

Read More

p53 gene therapy feasible, active in esophageal carcinoma patients

Read More

Futility trial indicates creatine and minocycline deserve phase III investigation

Read More

Antihypertensives linked to reduced incidence of Alzheimer's disease

Read More

Antitumor and antiangiogenic validation of anti-S1P MAb from Lpath

Read More

Lilly and Biosite collaborate on biomarkers for Xigris therapy

Read More

Orphan drug designation for Zadaxin in malignant melanoma

Read More

Schering-Plough and PTC Therapeutics establish HCV collaboration

Read More

New phase II study for SNS-595 in small cell lung cancer

Read More

Medidur phase III trial recommended to continue

Read More

Preliminary 48-week from phase III psoriasis trial of ISA-247

Read More

Exelixis and Sankyo to develop novel therapies for cardiovascular disease

Read More

Phase II trial studying VRX-496 for HIV

Read More

NanoViricides achieves positive results in initial FluCide-I studies

Read More

POET-1 study of Altropane ended early for evaluation of data

Read More

NicOx and Merck to develop new antihypertensive drugs

Read More

Phase I/II study of obesity drug TM-30338 meets endpoints

Read More

Atorvastatin/glatiramer combination synergistic in multiple sclerosis model

Read More

LY-450139 investigated in Alzheimer's disease

Read More

RON: A novel target for anticancer therapy

Read More

OSI-930 reported safe in healthy volunteers

Read More

Thiovir active against H5N1 avian influenza chimeric virus strains

Read More

Elan completes sale of European Prialt rights to Eisai

Read More

Three new studies evaluate GEM OS1 in orthopedic indications

Read More

STRIDE study of I-vation Intravitreal Implant completes enrollment

Read More

Recent patents cover novel compounds for Alzheimer's and other neurological disorders

Read More

Therapeutic agents for gastrointestinal disorders disclosed in recent patent literature

Read More

Novel HIV vaccines jointly reported by Progenics and the Sloan-Kettering Institute

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe